Author:
Sega Emanuela I.,Low Philip S.
Publisher
Springer Science and Business Media LLC
Reference99 articles.
1. Bettio, A., Honer, M., Muller, C., Bruhlmeier, M., Muller, U., Schibli, R., et al. (2006). Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors. Journal of Nuclear Medicine, 47, 1153–1160.
2. Breeman, W. A., Kwekkeboom, D. J., de Blois, E., de Jong, M., Visser, T. J., & Krenning, E. P. (2007). Radiolabelled regulatory peptides for imaging and therapy. Anticancer Agents in Medicinal Chemistry, 7, 345–357.
3. Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., et al. (2007). 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. Journal of Nuclear Medicine, 48, 508–518.
4. Grotzinger, C., & Wiedenmann, B. (2004). Somatostatin receptor targeting for tumor imaging and therapy. Annals of the New York Academy of Sciences, 1014, 258–264.
5. Breeman, W. A., de Jong, M., Kwekkeboom, D. J., Valkema, R., Bakker, W. H., Kooij, P. P., et al. (2001). Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. European Journal of Nuclear Medicine, 28, 1421–1429.
Cited by
258 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献